⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NMRA News
Neumora Therapeutics, Inc. Common Stock
Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
NMRA
Neumora Therapeutics to Participate in Upcoming Conferences in November
globenewswire.com
NMRA
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
globenewswire.com
NMRA
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
globenewswire.com
NMRA
Neumora Therapeutics to Host Virtual R&D Day on October 27
globenewswire.com
NMRA